Private Advisory Group LLC Bristol Myers Squibb CO Transaction History

Private Advisory Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $5.17 Million - $5.86 Million	107,730 New	107,730 $5.84 Million
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $201,514 - $262,858	-4,095 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$42.77 - $50.71 $1.1 Million - $1.3 Million	-25,663 Reduced 86.24%	4,095 $208,000
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $606,787 - $670,974	-13,599 Reduced 31.37%	29,758 $1.35 Million
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $66,216 - $85,866	1,358 Added 3.23%	43,357 $2.25 Million
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $40,067 - $45,193	726 Added 1.76%	41,999 $2.47 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $2.09 Million - $2.6 Million	41,273 New	41,273 $2.28 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Private Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisory Group LLC with notifications on news.